For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $79.03 in the prior trading day, Metlife Inc (NYSE: MET) closed at $79.24, up 0.27%. In other words, the price has increased by $0.27 from its previous closing price. On the day, 1.96 million shares were traded. MET stock price reached its highest trading level at $79.47 during the session, while it also had its lowest trading level at $78.48.
Ratios:
Our goal is to gain a better understanding of MET by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on January 23, 2025, initiated with a Market Perform rating and assigned the stock a target price of $97.
On October 09, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $97.
On September 05, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $91.Barclays initiated its Overweight rating on September 05, 2024, with a $91 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 31 ’25 when Metlife 401(k) Plan Large cap bought 209 shares for $74.79 per share.
MetLife Separate Account SPI bought 360 shares of MET for $28,282 on Jul 28 ’25. On Jun 27 ’25, another insider, MetLife 401(k) Plan Trust, who serves as the Affiliate discretionary manage of the company, bought 1,024 shares for $79.96 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MET now has a Market Capitalization of 52696657920 and an Enterprise Value of 70413664256. As of this moment, Metlife’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.43, and their Forward P/E ratio for the next fiscal year is 7.84. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.18. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.72 while its Price-to-Book (P/B) ratio in mrq is 1.91. Its current Enterprise Value per Revenue stands at 0.964 whereas that against EBITDA is 9.715.
Stock Price History:
The Beta on a monthly basis for MET is 0.85, which has changed by 0.06591332 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, MET has reached a high of $89.05, while it has fallen to a 52-week low of $65.21. The 50-Day Moving Average of the stock is 1.79%, while the 200-Day Moving Average is calculated to be -1.19%.
Shares Statistics:
The stock has traded on average 3.02M shares per day over the past 3-months and 3076890 shares per day over the last 10 days, according to various share statistics. A total of 666.83M shares are outstanding, with a floating share count of 557.60M. Insiders hold about 16.15% of the company’s shares, while institutions hold 75.20% stake in the company. Shares short for MET as of 1753920000 were 7444390 with a Short Ratio of 2.46, compared to 1751241600 on 7061686. Therefore, it implies a Short% of Shares Outstanding of 7444390 and a Short% of Float of 1.35.
Dividends & Splits
In the trailing 12 months, MET’s forward annual dividend rate was 2.203, compared to 2.23 this year. Against a Trailing Annual Dividend Yield of 0.027875492The stock’s 5-year Average Dividend Yield is 3.1. The current Payout Ratio is 36.26% for MET, which recently paid a dividend on 2025-08-05 with an ex-dividend date of 2025-08-05. Stock splits for the company last occurred on 2017-08-07 when the company split stock in a 1122:1000 ratio.
Earnings Estimates
The current market rating for Metlife Inc (MET) reflects the collective analysis of 10.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $2.38, with high estimates of $2.54 and low estimates of $2.24.
Analysts are recommending an EPS of between $8.94 and $8.33 for the fiscal current year, implying an average EPS of $8.64. EPS for the following year is $10.12, with 14.0 analysts recommending between $10.61 and $9.8.
Revenue Estimates
5 analysts predict $18.59B in revenue for the current quarter. It ranges from a high estimate of $19.09B to a low estimate of $18.2B. As of the current estimate, Metlife Inc’s year-ago sales were $17.61BFor the next quarter, 5 analysts are estimating revenue of $19.1B. There is a high estimate of $20.05B for the next quarter, whereas the lowest estimate is $18.16B.
A total of 6 analysts have provided revenue estimates for MET’s current fiscal year. The highest revenue estimate was $75.74B, while the lowest revenue estimate was $73.11B, resulting in an average revenue estimate of $74.66B. In the same quarter a year ago, actual revenue was $73.05BBased on 7 analysts’ estimates, the company’s revenue will be $78.05B in the next fiscal year. The high estimate is $80B and the low estimate is $74.41B.
